FIT Biotech Releases Immunomodulator FIT-06 Study Results – Pharmaceutical Business Review


The Hindu
FIT Biotech Releases Immunomodulator FIT-06 Study Results
Pharmaceutical Business Review
This is expected to be an alternative to antiretroviral therapy (ART) for HIV-infected patients. FIT-06 is a DNA-based vaccine developed by FIT Biotech
Phase II Data from FIT Biotech's HIV Immunotherapy Show Reduction in Viral Business Wire (press release)

all 2,739 news articles »


Post to Twitter Tweet This Post